Efficacy and Safety of Sirolimus in the Treatment of Crohn's Disease With Stenosis

Trial Profile

Efficacy and Safety of Sirolimus in the Treatment of Crohn's Disease With Stenosis

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Jun 2017

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 May 2017 Planned number of patients changed from 200 to 50.
    • 24 May 2017 Planned End Date changed from 1 Mar 2017 to 30 Dec 2019.
    • 24 May 2017 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top